Search
Fresenius Medical Care AG
FMSAdd to Watchlist
22.705USD
-0.535-2.30%
Close 06/29, 16:00（ET）Quotes delayed by 15 min
12.13BMarket Cap
12.12P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-2.30%
5 Days
-2.93%
1 Month
+5.26%
6 Months
-5.04%
Year to Date
-4.68%
1 Year
-19.51%
Key Figures
23.170Open
23.190High
863.83KVolume
12.12P/E TTM
4.84P/E Dynamic
1.364Dividend TTM
0.31%Turnover Ratio
23.240Prev. Close
22.585Low
10.38MTurnover
10.90P/E Static
0.41P/B
6.01%Div Yield TTM
3.73%ROA
29.06552wk High
1.57Volume Ratio
581.79MNet Profit
279.29MShares
1.8731EPS TTM
0.78Beta
7.01%ROE
20.02052wk Low
2.60%Amplitude
25.57%Gross Margin
12.13BMarket Cap
7.98Reward/Risk
0.97%Risk Rate
TradingKey Stock Score of Fresenius Medical Care AG
Currency: USD Updated: 2026-06-29Key Insights
Fresenius Medical Care AG's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 41 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Sell, with the highest price target at 22.13.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Fresenius Medical Care AG's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Fresenius Medical Care AG Highlights
StrengthsRisks
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 22.13B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 78.64%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 78.64%.
Undervalued
The company’s latest PE is 12.12, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 48.53M shares, increasing 0.28% quarter-over-quarter.
Held by Richard Pzena
Star Investor Richard Pzena holds 31.22M shares of this stock.
Analyst Rating
Based on
5
analysts
Sell
Current Rating
22.126
Target Price
-4.79%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Fresenius Medical Care AG News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Fresenius Medical Care AG Info
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Ticker SymbolFMS
CompanyFresenius Medical Care AG
CEOCordola (Craig)
Websitehttps://www.freseniusmedicalcare.com/
Related Instruments
-1.97%
-1.34%
-1.50%
+0.31%
-1.73%
-0.74%
-0.71%
-0.09%
+0.08%
-1.83%
-1.45%
-1.76%
-1.57%
+0.44%
+1.90%
+1.33%
-0.49%
-2.82%
+3.97%
-2.31%Popular Instruments
52274.000
+120.800 (+0.23%)
29791.900
+84.200 (+0.28%)
7443.200
+11.000 (+0.15%)
15578.000
+127.000 (+0.82%)
69814.000
-660.000 (-0.94%)
6297.200
+41.400 (+0.66%)
70.951
+0.635 (+0.90%)
281.740
-2.040 (-0.72%)
194.970
+2.440 (+1.27%)
4025.250
+9.660 (+0.24%)
FAQs
What is the current price of Fresenius Medical Care AG (FMS)?
The current price of Fresenius Medical Care AG (FMS) is 22.70.
What is the symbol of Fresenius Medical Care AG?
The ticker symbol of Fresenius Medical Care AG is FMS.
What is the 52-week high of Fresenius Medical Care AG?
The 52-week high of Fresenius Medical Care AG is 29.07.
What is the 52-week low of Fresenius Medical Care AG?
The 52-week low of Fresenius Medical Care AG is 20.02.
What is the market capitalization of Fresenius Medical Care AG?
The market capitalization of Fresenius Medical Care AG is 6.34B.
Is Fresenius Medical Care AG (FMS) currently rated as Buy, Hold, or Sell?
According to analysts, Fresenius Medical Care AG (FMS) has an overall rating of Sell, with a price target of 22.13.
What is the Earnings Per Share (EPS TTM) of Fresenius Medical Care AG (FMS)?
The Earnings Per Share (EPS TTM) of Fresenius Medical Care AG (FMS) is 1.89.
